Biomarkers Healthcare is now a NABL Certified Laboratory
EVERY PATIENT IS UNIQUE
EVERY PATIENT IS UNIQUE
Biomarkers Healthcare is now a NABL Certified Laboratory
Artificial intelligence (AI) is gradually changing medical practice. With recent progress in digitized data acquisition, machine learning and computing infrastructure, AI applications are expanding into areas that were previously thought to be only the province of human experts.
Interrogation of tissue informs on patient management through delivery of a diagnosis together with associated clinically relevant data.
Biomarker assays have brought significant challenges to bioanalytical laboratories that historically have provided pharmacokinetic analytical services to the drug development industry.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused an ongoing pandemic of new coronavirus pneumonia (corona virus disease 2019, COVID-19).
Emerging infectious diseases, the persistent potential for destabilising pandemics, remain a global threat leading to excessive morbidity and mortality.
© 2021 Biomarkers Healthcare Pvt. Ltd. All rights reserved